Exercise therapy in cancer prevention and treatment
Fink, H. et al. Global and regional cancer burden attributable to modifiable risk factors to inform prevention. Nat.…
UCLA researcher wins the 2026 Albany Prize for revolutionary cancer therapy discoveries
Dr. Dennis Slamon, a pioneering oncologist and researcher at the UCLA Health Jonsson Comprehensive Cancer Center, has been…
Simple urine test can accurately diagnose and track bladder cancer
A simple urine test devised by researchers at Stanford Medicine and the VA Palo Alto Health Care System…
Varying mutation rates in healthy organs explain cancer risk
A new study by scientists at City of Hope® and TGen, part of City of Hope, found surprisingly…
Childhood cancer survivors face severe mental health challenges as adults
Consultant and researcher Magnus Aasved Hjort believes that people who survive childhood cancer should receive far better support…
Wildfire smoke poses greater health risks than other pollution
As climate change drives more frequent and intense wildfires, researchers at the Icahn School of Medicine at Mount…
Mindfulness and tai chi practices help cancer survivors manage symptoms
The cancer journey for many patients doesn’t end after treatment. Many live with long-term side effects that affect…
New prostate cancer screening advances improve early detection
Did you know that about 1 in 8 men will be diagnosed with prostate cancer during their lifetime?…
Study maps rising lifetime risk of digestive cancers in China
The global landscape of oncology is shifting, and nowhere is this transition more complex or consequential than in…
Scallop-derived plasmalogens may support brain health and memory
The study, funded by B&S Corporation Co., Ltd., which manufactures and markets scallop plasmalogen, evaluated memory and brain…
Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer
Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the publication of a collaborative…
Fixed-dose inotuzumab ozogamicin (INO) combined with Vincristine and Prednisone (VP) regimen as induction therapy for newly diagnosed B-cell acute lymphocytic leukemia (B-ALL): a multi-center, open-label, single-arm, prospective clinical study
Adult B-ALL exhibits significant heterogeneity and poor prognosis compared with the pediatric population. While the complete remission (CR)…